BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29899063)

  • 1. CDK6 Antagonizes p53-Induced Responses during Tumorigenesis.
    Bellutti F; Tigan AS; Nebenfuehr S; Dolezal M; Zojer M; Grausenburger R; Hartenberger S; Kollmann S; Doma E; Prchal-Murphy M; Uras IZ; Höllein A; Neuberg DS; Ebert BL; Ringler A; Mueller AC; Loizou JI; Hinds PW; Vogl C; Heller G; Kubicek S; Zuber J; Malumbres M; Farlik M; Villunger A; Kollmann K; Sexl V
    Cancer Discov; 2018 Jul; 8(7):884-897. PubMed ID: 29899063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Cdk6 and Ccnd1 in chondrocytes inhibited chondrocyte maturation and caused p53-dependent apoptosis without enhancing proliferation.
    Ito K; Maruyama Z; Sakai A; Izumi S; Moriishi T; Yoshida CA; Miyazaki T; Komori H; Takada K; Kawaguchi H; Komori T
    Oncogene; 2014 Apr; 33(14):1862-71. PubMed ID: 23624920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-26a inhibits multiple myeloma cell growth by suppressing cyclin-dependent kinase 6 expression.
    Xu YY; Song YQ; Huang ZM; Zhang HB; Chen M
    Kaohsiung J Med Sci; 2019 May; 35(5):277-283. PubMed ID: 30897301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR inhibition in glioblastoma cells induces G2/M arrest and is independent of p53.
    Kapoor GS; Christie A; O'Rourke DM
    Cancer Biol Ther; 2007 Apr; 6(4):571-9. PubMed ID: 17457042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdk4 and Cdk6 cooperate in counteracting the INK4 family of inhibitors during murine leukemogenesis.
    Rodríguez-Díez E; Quereda V; Bellutti F; Prchal-Murphy M; Partida D; Eguren M; Kollmann K; Gómez de Cedrón M; Dubus P; Cañamero M; Martínez D; Sexl V; Malumbres M
    Blood; 2014 Oct; 124(15):2380-90. PubMed ID: 25157181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing.
    Cabrita MA; Vanzyl EJ; Hamill JD; Pan E; Marcellus KA; Tolls VJ; Alonzi RC; Pastic A; Rambo TM; Sayed H; McKay BC
    PLoS One; 2016; 11(2):e0148529. PubMed ID: 26840126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
    Gailllard B; Cornillet-Lefebvre P; Le QH; Maloum K; Pannetier M; Lecoq-Lafon C; Grange B; Jondreville L; Michaux L; Nadal N; Ittel A; Luquet I; Struski S; Lefebvre C; Gaillard JB; Lafage-Pochitaloff M; Balducci E; Penther D; Barin C; Collonge-Rame MA; Jimenez-Poquet M; Richebourg S; Lemaire P; Defasque S; Radford-Weiss I; Bidet A; Susin SA; Nguyen-Khac F; Chapiro E;
    Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CDK6 in cancer.
    Nebenfuehr S; Kollmann K; Sexl V
    Int J Cancer; 2020 Dec; 147(11):2988-2995. PubMed ID: 32406095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes.
    Pappas K; Xu J; Zairis S; Resnick-Silverman L; Abate F; Steinbach N; Ozturk S; Saal LH; Su T; Cheung P; Schmidt H; Aaronson S; Hibshoosh H; Manfredi J; Rabadan R; Parsons R
    Mol Cancer Res; 2017 Aug; 15(8):1051-1062. PubMed ID: 28483946
    [No Abstract]   [Full Text] [Related]  

  • 11. Overexpression of p53 protein in human tumors.
    Inoue K; Kurabayashi A; Shuin T; Ohtsuki Y; Furihata M
    Med Mol Morphol; 2012 Jun; 45(3):115-23. PubMed ID: 23001293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma.
    AbuHammad S; Cullinane C; Martin C; Bacolas Z; Ward T; Chen H; Slater A; Ardley K; Kirby L; Chan KT; Brajanovski N; Smith LK; Rao AD; Lelliott EJ; Kleinschmidt M; Vergara IA; Papenfuss AT; Lau P; Ghosh P; Haupt S; Haupt Y; Sanij E; Poortinga G; Pearson RB; Falk H; Curtis DJ; Stupple P; Devlin M; Street I; Davies MA; McArthur GA; Sheppard KE
    Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17990-18000. PubMed ID: 31439820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27 inhibits CDK6/CCND1 complex formation resulting in cell cycle arrest and inhibition of cell proliferation.
    Li N; Zeng J; Sun F; Tong X; Meng G; Wu C; Ding X; Liu L; Han M; Lu C; Dai F
    Cell Cycle; 2018; 17(19-20):2335-2348. PubMed ID: 30317923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma.
    Kikkawa N; Kinoshita T; Nohata N; Hanazawa T; Yamamoto N; Fukumoto I; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Int J Oncol; 2014 Jun; 44(6):2085-92. PubMed ID: 24647829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting CDK6 in cancer: State of the art and new insights.
    Tadesse S; Yu M; Kumarasiri M; Le BT; Wang S
    Cell Cycle; 2015; 14(20):3220-30. PubMed ID: 26315616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine Promotes WRL68 Cells Proliferation Due to the Mutant p53 Gain-of-Function by Activating CDK6-p53-RS-PIN1-STAT1 Signaling Pathway.
    Wang H; Chen L; Zhou T; Zhang Z; Zeng C
    Chem Res Toxicol; 2020 Sep; 33(9):2361-2373. PubMed ID: 32820905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival.
    Wang H; Nicolay BN; Chick JM; Gao X; Geng Y; Ren H; Gao H; Yang G; Williams JA; Suski JM; Keibler MA; Sicinska E; Gerdemann U; Haining WN; Roberts TM; Polyak K; Gygi SP; Dyson NJ; Sicinski P
    Nature; 2017 Jun; 546(7658):426-430. PubMed ID: 28607489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cdk6: At the interface of Rb and p53.
    Nebenfuehr S; Bellutti F; Sexl V
    Mol Cell Oncol; 2018; 5(5):e1511206. PubMed ID: 30263948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of high levels of the p53 and p130 growth-suppressing proteins in cell lines stably over-expressing cyclin-dependent kinase 6 (cdk6).
    Nagasawa M; Gelfand EW; Lucas JJ
    Oncogene; 2001 May; 20(23):2889-99. PubMed ID: 11420701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
    Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
    Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.